Skip to content
No results
  • About Us
  • Contact Us
  • Disclaimer
  • Event Venues
  • Events and Conferences
  • Home
  • Organizer Dashboard
  • Organizer Dashboard
  • Privacy Policy
  • Submit Organizer Form
  • Submit Organizer Form
  • Submit Venue Form
  • Submit Venue Form
  • Subscribe
  • Terms and Conditions
  • Venue Dashboard
  • Venue Dashboard
  • About Us
  • Contact Us
The Pharma Data

  • News
  • Press Releases
  • Research
  • Business
  • Regulatory
  • Events and Conferences
The Pharma Data
Planet
  • NewsRegulatory

Planet DDS 2026 Dental Outlook Reports More New Patients and Fewer No-Shows Across the Industry

  • The Pharma Data
  • March 12, 2026

Planet DDS 2026 Dental Outlook Shows More New Patients, Fewer No-Shows Across the Industry Planet DDS, a leading provider of cloud-based, enterprise-grade dental software solutions, announced the release of its 2026…

Read MorePlanet DDS 2026 Dental Outlook Reports More New Patients and Fewer No-Shows Across the Industry
Tempus
  • Research

Tempus AI Study Reveals Impact of Advanced Genomic Profiling in Detecting Actionable Findings

  • The Pharma Data
  • March 12, 2026

Tempus Announces Study Highlighting the Role of Advanced Genomic Profiling Features in Identifying Clinically Actionable Findings Tempus AI, Inc. a technology company leading the adoption of AI to advance precision…

Read MoreTempus AI Study Reveals Impact of Advanced Genomic Profiling in Detecting Actionable Findings
Veristat
  • Regulatory

Veristat Broadens Regulatory and Clinical Services for Chinese Companies Seeking EU Market Entry

  • The Pharma Data
  • March 12, 2026

Veristat Expands Regulatory and Clinical Services to Chinese Drug and Device Companies Seeking Efficient Way to Enter European Markets Veristat, a global clinical research organization (CRO) and consultancy specializing in…

Read MoreVeristat Broadens Regulatory and Clinical Services for Chinese Companies Seeking EU Market Entry
Precision BioSciences
  • Research

Precision BioSciences Secures U.S. Patent Allowances for PBGENE-HBV Program

  • The Pharma Data
  • March 11, 2026

Precision BioSciences Receives U.S. Patent Allowances Covering the PBGENE-HBV Program Precision BioSciences, Inc. a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for…

Read MorePrecision BioSciences Secures U.S. Patent Allowances for PBGENE-HBV Program
Parabilis
  • ResearchNews

Parabilis Medicines’ Zolucatetide Receives FDA Orphan Drug Designation for Desmoid Tumor Treatment

  • The Pharma Data
  • March 11, 2026

Parabilis Medicines’ Zolucatetide, the First and Only Direct Inhibitor of the Elusive β-catenin:TCF Interaction, Receives FDA Orphan Drug Designation for the Treatment of Desmoid Tumors Parabilis Medicines, a clinical-stage biopharmaceutical…

Read MoreParabilis Medicines’ Zolucatetide Receives FDA Orphan Drug Designation for Desmoid Tumor Treatment
Curatis
  • Press Releases

Curatis Grants Neupharma Exclusive Japan Rights for Corticorelin (C-PTBE-01)

  • The Pharma Data
  • March 11, 2026

Curatis and Neupharma Announce Exclusive Licensing Agreement to Develop and Market Corticorelin (C-PTBE-01) for the Treatment of Peritumoral Brain Edema in Japan Curatis Holding AG and Neupharma Co., Ltd. a…

Read MoreCuratis Grants Neupharma Exclusive Japan Rights for Corticorelin (C-PTBE-01)
TIXiMED
  • Research

TIXiMED: Oral TIX100 Prevents Post-GLP-1 Weight Regain in Preclinical Study

  • The Pharma Data
  • March 11, 2026

TIXiMED Reports Promising Preclinical Results for Oral TIX100 in Preventing Weight Regain After GLP-1 Therapy TIXiMED a clinical-stage pharmaceutical company focused on developing innovative treatments for diabetes and metabolic diseases,…

Read MoreTIXiMED: Oral TIX100 Prevents Post-GLP-1 Weight Regain in Preclinical Study
Verasonics
  • Press Releases

Verasonics Updates Vantage NXT with New Ultrasound Features

  • The Pharma Data
  • March 11, 2026

Verasonics Announces Vantage® NXT Platform Update Featuring Encoder Integration, Focused Ultrasound 2D/3D Software, New 8 MHz Matrix Array Transducer Verasonics, Inc., the leader in research ultrasound, announced the release of a significant…

Read MoreVerasonics Updates Vantage NXT with New Ultrasound Features
GeneDx
  • News

GeneDx Launches Genetic Testing Program with Zevra Therapeutics

  • The Pharma Data
  • March 11, 2026

GeneDx to Launch Genetic Testing Program with Zevra Therapeutics to Support Patients with Suspected Niemann-Pick Disease Type C GeneDx the leader in rare disease diagnosis and improving health through the…

Read MoreGeneDx Launches Genetic Testing Program with Zevra Therapeutics
QT Imaging
  • Regulatory

QT Imaging Wins FDA Clearance for Enhanced Breast Acoustic CT Scanner

  • The Pharma Data
  • March 11, 2026

QT Imaging Receives FDA Clearance for Its Breast Acoustic CT Scanner Enhanced Configuration to Improve Posterior Breast Imaging Coverage QT Imaging Holdings, Inc. a medical device company dedicated to transforming…

Read MoreQT Imaging Wins FDA Clearance for Enhanced Breast Acoustic CT Scanner
Butterfly
  • Press Releases

Butterfly Network Names David Horsley SVP of Innovation

  • The Pharma Data
  • March 11, 2026

Butterfly Network Appoints David Horsley as Senior Vice President, Innovation – Butterfly Embedded™ Butterfly Network, Inc. a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, announced…

Read MoreButterfly Network Names David Horsley SVP of Innovation
Vertex
  • Research

Vertex Reports Positive Week 36 Interim Results in Phase 3 RAINIER Trial of Povetacicept for IgA Nephropathy

  • The Pharma Data
  • March 10, 2026

Vertex Announces Positive Week 36 Interim Analysis Results for Primary and All Secondary Endpoints in the RAINIER Phase 3 Trial of Povetacicept in Adults With IgA Nephropathy Vertex Pharmaceuticals Incorporated…

Read MoreVertex Reports Positive Week 36 Interim Results in Phase 3 RAINIER Trial of Povetacicept for IgA Nephropathy
PrevNext
UK Biotech Day
Global Clinical Trial Supply Forum 2026 I Frankfurt, Germany

About

The Pharma Data is an Information-Centric Website focused mainly on the Pharmaceutical Industry Online It is a B2B Platform mainly focused on the latest Pharmaceutical News, Press releases, Industry-related updates, Events, and Conferences. With The Pharma Data, you can get all the information that happening in the Pharmaceutical industry.

Advertise With Us: marketing@thepharmadata.com

Latest Posts

  • UCB Expands Immunology Portfolio with Acquisition of Candid Therapeutics, Advancing Novel T-Cell Engager Strategy
  • J&J Statement on FDA Approval of STELARA® for Pediatric Crohn’s Disease
  • Incyte Wins FDA Approval for Jakafi XR™ Extended-Release Tablets Across Multiple Hematologic Indications
  • About Us
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Contact Us

Copyright © 2026 | The Pharma Data | Marnet Technologies Pvt Ltd | All Rights Reserved.